NOVATO, Calif., Feb. 24, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that company management will present at two upcoming investor conferences.
- JMP Securities Non-alcoholic Steatohepatitis (NASH) Workshop in New York on February 27, 2014. Patrice Rioux, M.D., Ph.D., Raptor's Chief Medical Officer, will present an overview of the company's development program in non-alcoholic fatty liver disease (NAFLD) during a panel discussion beginning at 9:30 a.m. EST.
- Cowen and Company, 34 th Annual Health Care Conference in Boston on March 4, 2014 at 9:20 a.m. EST/6:20 a.m. PST. Christopher Starr, Ph.D., Raptor's Chief Executive Officer will present. A live audio webcast and archive of the presentation will be available on the company website at www.raptorpharma.com .
CONTACT: Georgia Erbez Chief Financial Officer Raptor Pharmaceutical Corp. (415) 408-6231 firstname.lastname@example.org INVESTOR CONTACT: Westwicke Partners, LLC Robert H. Uhl Managing Director (858) 356-5932 email@example.com MEDIA CONTACT: Carolyn Hawley Canale Communications (619) 849-5375 firstname.lastname@example.org